Pensacola, FL, United States of America

Patrick Shannon

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: Cancer Prevention Pharmaceuticals, Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick Shannon. Retrieved from https://idiyas.com/inventor/patrick-shannon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Patrick Shannon

Introduction

Patrick Shannon is a notable inventor based in Pensacola, FL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of combination formulations. With a total of 4 patents to his name, Shannon's work has the potential to impact patient care and treatment options.

Latest Patents

One of his latest patents includes a fixed-dose combination formulation of eflornithine and sulindac. This formulation provides a pharmaceutically effective amount of both compounds, aimed at enhancing therapeutic efficacy. The patent also outlines methods of use and manufacture for these formulations, showcasing Shannon's innovative approach to drug development.

Career Highlights

Shannon is currently associated with Cancer Prevention Pharmaceuticals, Inc., where he continues to work on groundbreaking research. His focus on combination therapies reflects a growing trend in the pharmaceutical industry to improve treatment outcomes through innovative formulations.

Collaborations

Throughout his career, Shannon has collaborated with esteemed colleagues such as Roberto Carlos Bravo González and Jean Ducassou. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Patrick Shannon's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective drug formulations. His work continues to pave the way for advancements in cancer prevention and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…